Sanguine BioSciences Lands $5,534,250 New Financing Round

  • Feed Type
  • Date
    11/26/2014
  • Company Name
    Sanguine BioSciences
  • Mailing Address
    15335 Morrison Street Sherman Oaks, CA 91403 USA
  • Company Description
    Our mission is to facilitate and accelerate biomarker and personalized drug discovery by acknowledging the powerful role of the patient in research. We strive to develop meaningful relationships with patients that lead to empowerment and education. The Patient Portal will provide you information on how YOU can help accelerate research and treatments for your disease.
  • Website
    http://www.sanguinebio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,534,250
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy